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fibroblastic cancer cell lines (A549 lung cancer cells and HepG2 liver cancer cells) in which compound 5 
was the most toxic alkaloid with IC50 values ranging from 20 to 80 µM. 
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Abstract 
Annona muricata L. has been used traditionally in Indonesia to treat disease. Phytochemical studies on the alkaloid 
fractions from the root of Annona muricata L. from Malang-Indonesia resulted in the isolation of an unreported 
benzylisoquinoline alkaloid (+)-xylopine 5 as well as four known alkaloids (1-4).  The crude methanol extract and 
alkaloid fractions were tested against Plasmodium falciparum K1 and against bacteria (Escherichia coli, Klebsiella 
pneumonia, Acinetobacter buamanii, Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus) with 
insignificant activities (MIC > 32 µg/mL).  Individual alkaloids were tested against human suspension cancer 
cell line (HL-60 leukemia cells) and the human fibroblastic cancer cell lines (A549 lung cancer cells) and 




Indonesian medicinal plant; Annona muricata; alkaloid; anti-cancer; anti-malarial; anti-bacteria 
 
1. Introduction 
The Indonesian archipelago is acknowledged as a source of around 6,000 recorded medicinal plants, but 
only a few selected species have been investigated for the source of their potency (Nugraha and Keller 
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2011).  The indigenous population of Indonesia has relied on medicinal plants for traditional therapy against 
diseases, including the use of Annona muricata L. to treat malaria and bacterial infections. 
Annona muricata L. originated from tropical America and spread throughout Southern Eastern China, 
South East Asia to Northern Australia. It is part of the Annonaceae family which contains more than 2,000 
species within 130 genera. The genus Annona itself consists of 119 species including at least four, 
commonly used both as an edible fruit and as a medicine (Annona cherimola Mill., Annona muricata L., 
Annona squamosal L., Annona reticulata L.) with other species commonly used only in traditional 
medication including Annona ambotay Aubl., Annona senegalensis Pers.. 
To the indigenous Indonesian population, the leaves have been prepared to treat boils, spasm and as 
aphrodisiac agents (Syamsuhidayat and Hutapea 1991). In Indonesia, the fruit and leave are currently used 
to treat breast cancer while the stem and root have been used to treat malarial fever.  
In the early 20th century, elemental examination of the Annona plants began on the leaves, fruits and seeds. 
Study on volatile compounds of Vietnamese Annona glabra L., Annona squamosal L., Annona muricata 
L. and Annona reticulata L. comprised of β-caryophyllene as the major constituent (Thang et. al. 2013).  
Since 1980s with the development of chemical analysis instrumentation, a series of acetogenin were 
isolated from the Annona genus provided promising anti-cancer activity (Nugraha 2015). Phytochemical 
studies of A. muricata L. produced around 127 compounds of which almost 90% were acetogenins 
(Nugraha 2015). Notable acetogenins isolation work included the isolation of dieporeticanin-1, 
dieporeticanin-2, dieporeticenin, trieporeticanin, diepomuricanin, reticulatacin and solamin from seeds of 
Vietnamese Annona reticulata L. (Tam et. al. 1994) and the isolation of robustocin from the seeds of 
Brazilian Annona muricata L. (Gleye et. al. 2000). Annonacin, goniothalamicin and isoannonacin were 
moluscicidal potent acetogenins isolated from the leaves of Brazilian Anonna muricata L. (Luna et. al. 
2006).  Here, we reported the isolation of the previously unreported alkaloid constituents of the root of 
Annona muricata L. and their bioactivities.  
2. Result and discussion 
The root bark of A. muricata was collected from Malang-Indonesia and was initially powdered to ease 
extraction. The initial extract was obtained by stirring plant samples with methanol, then acidification with 
HCl solution followed by back extraction (CH2Cl2). Basification of the aqueous layer with ammonia 
solution followed by back extraction (CH2Cl2) produced an alkaloids fraction. Semi-preparative normal-
phase HPLC was able to isolate the alkaloids (+)-coclaurine 1 (Kashiwada, et al. 2005), (+)-reticuline 2 
(Oliveira da Cruz et al. 2011), argentinine 3 (Lopez-Martin et al. 2002), atherosperminine 4 (Lu et al. 1985) 
and the previously unreported (+)-xylopine 5 (Figure 1), with argentinine 3 reported here for the first time 
from A. muricata. The only previously reported examples of this alkaloid came from the related species A. 





R=H, (+) coclaurine 1 
R=OCH3, (+) reticuline 2 
 
R=H, argentinine 3 
R=OCH3, atherosperminine 4 
 
(+) xylopine 5 
   
Figure 1. Alkaloids obtained from the root bark of Annona muricata L. 
 
Compound 5 was isolated as brown solid. 1H-NMR and 13C-NMR spectral analysis are illustrated in the 
experimental section. The 13C-NMR spectrum revealed eighteen carbon resonances and APT spectral 
analysis confirmed the presence of eight quaternary (C), five methane (CH), four methylene (CH2), and one 
methyl (CH3) carbon atoms. Analysis of the 
1H-NMR spectra suggested the presence of one methoxy (-
OCH3) and one methylenedioxy (-O-CH2-O) moiety while the IR spectral analysis indicated no N-H 
bending at 1600 cm-1 and one medium N-H stretching signal at 3300 cm-1, suggesting the existence of a 
secondary amine (R-NH-R). Therefore, the existence of oxygen (x3), hydrogen (x1) and nitrogen (x1) 
atoms in the molecular structure is suggested. The molecular formula of C18H18NO3 was confirmed by 
HRESI-MS analysis with a peak at m/z 296.1295.  
The 1H-NMR spectrum of 5 showed a set of resonances at δH 8.00 (1H, d, 
3J = 7.5 Hz), 6.83 (1H, d, 3J = 
7.5 Hz) and 6.81 (1H, s), assigned to H11, H10, H8, respectively (Figure 2, A). This 1,3,4 tri-substituted 
aromatic ring contained quaternary carbons C7a, C9 and C11a which were assigned using gHMBC spectral 
analysis to resonances at δC 137.7, 160.6 and 125.0 ppm, respectively. In the 
1H-NMR spectrum, the singlet 
at δH 3.81 (3H, s) was distinctively assigned to –OCH3 which the gHMBC spectral analysis indicated a 
proton-carbon correlation with C9. In total, this suggested a 1,3,4-trisubstituted aromatic ring unit of 
compound 5 (Figure 2 A).  
 
Figure 2. Progressive molecular structure build of 5 based on NMR spectral analysis 
 
Further analysis of the 1H-NMR spectrum showed resonances at δH 2.87 (1H, m) and 2.70 (1H, m), assigned 
to the methylene H7a and H7b, respectively. Through gCOSY spectral analysis, these protons showed ortho 
proton-proton correlations with the proton resonance at δH 3.90 assigned to H6a (1H, m). Further, gHMBC 
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spectral analysis indicated a three bond proton-carbon correlation between H11 and carbon resonance at δC 
117.3 assigned to C1a while H8 also indicated a three bond correlation with the carbon resonance at δC 37.4 
assigned as the methylene C7. In the gHMBC spectral analysis, proton H7a, H7b and H6a showed proton-
carbon correlation with the carbon resonance at δC 127.2, assigned to C3b. Together with the previous 
analysis, the molecular structure building block B was established (Figure 2 B).  
Further, the 1H-NMR spectrum showed two proton systems at δH 6.03 (1H, s) and 5.90 (1H, s), assigned to 
a distinct acetal methylene group H12A and H12B, respectively (Figure 2 C). The gHMBC spectral analysis 
showed a proton-carbon correlation between the acetal methylene protons and two quaternary carbons at 
δC 143.3 and 148.6, assigned to C1 and C2, respectively. Further analysis of 
1H-NMR spectrum showed a 
singlet proton at δH 6.51, assigned to H3 which gHMBC spectral analysis showed the proton to correlate 
with C2 and carbon resonance at δC 127.2, assigned to C3b. Moreover, gHMBC spectral analysis showed 
H3 to correlate with methylene carbon resonance at δC 29.8 assigned as C4. The 
1H-NMR and gCOSY 
spectra showed proton resonances at δH 2.99 (m, 1H) and 2.67 (m, 1H), assigned to H4A and H4B, 
respectively whereas proton resonances at δH 3.33 (m, 1H) and 2.97 (m, 1H) were assigned to H5A and H5B, 
respectively. The chemical shift of methylene carbon C5 at 44.0 clearly suggested an electronegative group 
was adjacent, presumably the nitrogen functional group. This was confirmed by IR experiment which 
showed a distinct secondary amine stretch at 3310 cm-1. Therefore, the molecular structure of fragment C 
was established (Figure 2 C). By combining this evidence above, the molecular structure of xylopine was 
established (Figure 2 D) with selected proton-carbon correlations summarised in the figure S5 (see 
supplementary information). 
This alkaloid has only previously been reported in its sinister (R) optically active form with previously 
rotations of [∝] 25
𝐷
 of -21.5° (Bhaumik et al. 1979), -23.4° (Roblot et al. 1983), -38° (Lu et al. 1985) in 
methanol.  Here, we report for the first time the isolation of the opposite enantiomer, dextro xylopine 5 with 
an optical rotation of [∝] 25
𝐷
  +81° in methanol and the (S) stereogenic carbon. The previously isolated (-) 
isomer of xylopine was present in A. reticulate, A. squamosal, A. Montana, but our studies show the 
existence of (+)-xylopine alkaloid for the first time. 
Biological testing of the crude methanol extract and alkaloid fractions revealed insignificant anti-bacterial 
activities against Escherichia coli, Klebsiella pneumonia, Acinetobacter buamanii, Pseudomonas 
aeruginosa and Methicillin-resistant Staphylococcus aureus (Table 1). Testing against Plasmodium 
falciparum also indicated no anti-malarial potency. This result is contrary to traditional claims and uses in 
malarial and fever therapy. Further bioactivity testing revealed significant cytotoxicity against several 
cancer cell lines (Figure 3 and Figure 4).  
In addition, the methanol extract of the leaf was previously reported to possess low antimicrobial activity 
against Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa with MIC values of 1024, 256, 
1024 µg/mL, respectively (Dzotam et al. 2016). Insignificant antimicrobial activity was also reported on 
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the hydroethanolic extract of the leaves against Staphylococcus aureus (MIC ≥1024 µg/mL) (Bento et al. 
2013). Bacillus subtilis and Staphylococcus aureus were reported to be sensitive against benzene extract of 
wood of Brazilian Annona ambotay with inhibition diameter of 10 and 9 mm, respectively. The same result 
was produced by ethanolic extract of Brazilian Annona cherimolia with inhibition diameter value of 14 and 
11 mm, respectively (Carlos et. al. 2006). Crude ethanolic extract of leaves, stem and root of Cameroonian 
Annona muricata possessed anti-fungal activity against Cadida albicans, Candida glabrata, Candida 
cruzei, Candida lusitaniae, Cryptococcus neoformans, Candida paapsilosis and Candida tropicalis with 
MIC values vary from 1.9 to 15 mg/mL (Simo et. al. 2018). An additional study reported the crude methanol 
extract of leaves and stem of A. muricata were able to inhibit Plasmodium falciparum W2 growth by 36.8 
and 26.3 % at concentration of 10 µg/mL, respectively (Osorio et al. 2012). The crude leave extract species 
derived from various habitats in Malaysia revealed anti-breast cancer (MCF7) with IC50 values ranging 
from 221.67 – 799.67 µg/mL with no environmental effect discussed (Najmuddin et al. 2016). 
 
Table 1. Anti-plasmodium and antibacterial activities of crude methanol extract and alkaloid fraction from 




 Antibacterial    
(MIC, µg/mL) 
PF  EC KP AB PA MRSA 
Crude methanol extract i  >32 >32 >32 >32 >32 
Alkaloid fraction i  >32 >32 >32 >32 >32 
Coistin na  0.06 0.03 0.03 ≤0.025 na 
Daptomycin na  na na na na 1 
Mafloquine 0.0290*  na na na na na 
Note: *in µM; i: inactive; na: not available; PF: Plasmodium falciparum; EC: Escherichia coli; KP: 
Klebsiella pneumonia; AB: Acinetobacter baumannii; PA: Pseudomonas aeruginosa; SA: Methicillin-
resistant Staphylococcus aureus.  
 
Previously pharmacological reports on the five alkaloids in this study revealed reticuline to have gram-
positive selective antimicrobial against Staphylococcus aureus with MIC value of 500 µg/mL (Costa et al. 
2013). (+)-Coclaurine dimerization was reported to increase its antiplasmodial activity (Kashiwada et al. 
2005). Interestingly, typical dimerization of benzylisoquinolines such as dehatrine, also possessed potent 
anti-malarial activity against a chloroquine-resistant Plasmodium falciparum K1 with an IC50 value of 0.17 
µM (Kitagawa et al. 1993). (+) Reticuline and atherosperminine were reported to inhibit Plasmodium 








 (C)  
 
Figure 3. The concentration response curves for the specified compounds in the human suspension cancer 
cell line (HL-60 leukemia cells, (A)) and the human fibroblastic cancer cell lines (A549 lung cancer cells 
(B) and HepG2 liver cancer cells (C)). 
 
Five compounds were tested across three cell lines which included a human suspension cancer cell line 
(HL-60 leukemia cells) and two fibroblastic cell lines (A549 lung cancer cells and HepG2 liver cancer 
cells). Figure 3 (A-C) shows the typical concentration-response curves obtained from the MTT assay of 
each compound with the three cell lines.  The IC50 values are summarized in Figure 4. Compounds 1 and 2 
were relatively nontoxic across all three cell lines.  Their IC50 values were greater than 300 µM and could 
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not be determined due to solubility limitations.  The most toxic compound across the three cell lines (P< 
0.05-0.0001) was compound 5, exhibiting the lowest IC50 values (ranging from approximately 20-80 µM)). 
 
 
Figure 4.  Summary of the IC50 values obtained for the specified compounds in the human cancer cell lines: 
HL-60, A549 and HepG2 cells.  IC50 values for compounds 1 and 2 were not determined due to solubility 
limitations but were greater than 300 µM (as indicated by column arrow).  Each column represents the 
average IC50 value determined from triplicate MTT assays. 
 
3. Experimental 
3.1. General experimental procedures 
Silica gel (Merck Silica Gel 60, 0.063-0.200 mm). Analytical HPLC was performed in a Waters 1525 binary 
HPLC pump coupled with Waters 2487 dual λ absorbance detector. A symmetry ® C18 column was used 
(4.9 x 150 mm, 5 μm). Semi-preparative HPLC was performed in a Waters LC system coupled with Waters 
2489 UV/Visible detector. An OBD SunfireTM C18 semi-preparative HPLC column (19 x 150 mm, 5 μm) 
was used. ESI-MS spectra were collected from Waters platform LCZ mass spectrometer (low resolution) 
and Waters QTof Ultima mass spectrometer (high resolution). MS/MS experiment were carried out on 
Waters (micromass) Quattro microTM. NMR spectra were obtained from Varian Unity Inova-500 MHz 
NMR spectrometer. Biological assays for anti-malarial activities were performed at the National Centre for 
Genetic Engineering and Biotechnology, Thailand. The antimicrobial screening was performed by CO-
ADD (The Community for Antimicrobial Drug Discovery), funded by the Welcome Trust (UK) and The 
University of Queensland (Australia). 
3.2. Plant material: Annona muricata L. (Annonaceae) root were collected from Malang, Indonesia and 
identified at the School of Pharmacy, University of Jember, Indonesia, where sample vouchers are kept 
under accession AMR. The root was cleaned, washed, sliced, sun-dried and then powdered. 
8 
 
3.3. Extraction: A suspension of the powdered root (200 g) in methanol (2.5 L) was stirred for 24 hr, and 
then filtered and the filtrate concentrated producing a brown sticky semi-solid (28.1 g). A portion of extract 
(10.0 g) was acidified with 5% HCl and extracted with CH2Cl2 (3 x 200 mL), the water layer was then 
basified with NH4OH solution until pH 12. This solution was then extracted with CH2Cl2 (4 x 200 mL) and 
the organic layer was vacuum dried to produce alkaloid extract (1.35 g).  
3.4. Isolation: The alkaloid extract (500 mg) was re-dissolved in MeOH (10 mL) and filtered through HPLC 
filter (0.45 µm). The sample was subjected to semi-preparative normal HPLC with gradient eluent from 
90% to 55% solvent A within 50 minutes (solvent A: 0.1% TFA in H2O; solvent B: 0.1% TFA in 
acetonitrile) to produce (+)-coclaurine 1, (+)-reticuline 2, argentinine 3, atherosperminine 4 and previously 
unreported (+)-xylopine 5. 
(+)-xylopine (5) 
Brown solid (0.32 mg/g dried plant sample); [∝] 25
𝐷
 of +81° (methanol); IR [cm-1] 3300 (m), 2919 (m), 2850 
(m), 1650 (m), 1606 (s), 1500 (s), 1225 (s), 1051 (s), 447 (s); 13H-NMR (500 Hz, CD3OD): δ 8.00 (d, 
3J = 
7.5, 1H, H11), 6.83 (d, 3J = 7.5, 1H, H10), 6.81 (s, 1H, H8), 6.51 (s, 1H, H3), 6.03 (s, 1H, H12a), 5.90 (s, 
1H, H12b), 3.90 (m, 1H, H6a), 3.81 (s, 3H, C9-OCH3), 3.33 (m, 1H, H5a), 2.99 (m, 1H, H4a), 2.97 (m, 1H, 
H5b), 2.87 (m, 1H, H7a), 2.70 (m, 1H, H7b), 2.67 (m, 1H, H4b); 13C-NMR (125 Hz, CD3OD): δ 160.6 
(C9), 148.6 (C2), 143.3 (C1), 137.7 (C7a), 129.6 (C11), 127.5 (C3b), 127.2 (C3a), 125.0 (C11a), 117.3 
(C1a), 114.5 (C8), 113.4 (C10), 107.9 (C3), 102.0 (C12), 55.7 (C9-OCH3), 54.6 (C6a), 44.0 (C5), 37.4 
(C7), 29.8 (C4); ESMS: 296 (M+H)+  HRESIMS: calculated 296.1287, found 296.1295 (C18H18NO3) 
3.5. Bioactivity testing: Anti-malarial activity was determined against Plasmodium falciparum K1 based 
on the microculture radioisotope technique (Desjardins et al. 1979). Cytotoxicity was tested against human 
suspension cancer cell line (HL-60 leukemia cells) and the human fibroblastic cancer cell lines (A549 lung 
cancer cells) and HepG2 liver cancer cells (see supplementary information). Anti-viral activity was tested 
against herpes simplex virus type 1 using a green fluorescent protein assay (Haritakun et al. 2010). 
Antimicrobial activities were tested against Escherichia coli ATCC 25922 (GN_001), Klebsiella 
pneumoniae ATCC 700603 (GN_003), Acinetobacter baumannii ATCC 19606 (GN_034), Pseudomonas 
aeruginosa ATCC 27853 (GN_042) and Staphylococcus aureus ATCC 43300 (MRSA) (GP_020). 
4. Conclusion  
Our investigation into the phytochemistry of the root of Annona muricata L. has resulted in the isolation of 
five alkaloids including the new compound, (+)-xylopine 5. We reported the isolation of argentinine for the 
first time from the Annona muricata L. with the only previous reports coming from the two closest species 
Annona muricata and Annona Montana. Therefore, this alkaloid might be useful for chemotaxonomical 
studies. Bioactivity testing revealed compound 5 as the most toxic constituent among the alkaloids of the 
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